Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naja kaouthia cobra venom

Thrombosis and Haemostasis

Volumn 80, Issue 3, 1998, Pages 499-505

  Hamako, Jiharu ^a   Matsui, Taei ^a   Nishida, Sachiyo ^b   Nomura, Shosaku ^c   Fujimura, Yoshihiro ^b   Ito, Masayuki ^a   Ozeki, Yasuhiro ^d   Titani, Koiti ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COLLAGEN; DISULFIDE; KAOUTHIAGIN; METALLOPROTEINASE; MONOCLONAL ANTIBODY; MONOMER; SNAKE VENOM; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; THROMBOCYTE AGGREGATION; TOXIN STRUCTURE;

EID: 0031787654     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615236     Document Type: Article

References (42)

1. Girma JP, Meyer D, Verweij CL, Pannekoek H, Sixma JJ. Structure-function relationship of human von Willebrand factor. Blood 1987; 70: 605-11.
2. Howard MA, Firkin BG. Ristocetin - a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 1971; 26: 362-9.
3. Read MS, Shermer RW, Brinkhous KM. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc Natl Acad Sci USA 1978; 75: 4514-18.
4. Hamako J, Matsui T, Suzuki M, Ito M, Makita K, Fujimura Y, Ozeki Y, Titani K. Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom. Biochem Biophys Res Commun 1996; 226: 273-9.
5. Matsui T, Hamako J, Suzuki M, Hayashi N, Ito M, Makita K, Fujimura Y, Ozeki Y, Titani K. Complete amino acid sequence of bitiscetin, a novel von Willebrand factor modulator protein, purified from snake venom of Bitis arietans. Res Commun Biochem Cell Mol Biol 1997; 1: 271-84.
6. Fujimura Y, Kawasaki T, Titani K. Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb Haemost 1996; 76: 633-9.
7. Pens M, Lu W, Kirby EP. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry 1991; 30: 11529-36.
8. Dennis MS, Henzel WJ, Pitti RM, Lipari MT, Napier MA, Deisher TA, Bunting S, Lazarus RA. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci USA 1990; 87: 2471-5.
9. Scarborough RM, Naughton MA, Teng W, Rose JW, Phillips DR, Nannizzi L, Arfsten A, Campbell AM, Charo IF. Design of potent and specific integrin antagonists: peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem 1993; 268: 1066-73.
10. Chopek MW, Girma JP, Fujikawa K, Davie EW, Titani K. Human von Willebrand factor: a multivalent protein composed of identical subunits. Biochemistry 1986; 25: 3146-55.
11. Usami Y, Fujimura Y, Suzuki M, Ozeki Y, Nishio K, Fukui H, Titani K. Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca. Proc Natl Acad Sci USA 1993; 90: 928-32.
12. Katayama M, Hirai S, Kato I, Titani K. Immunoenzymometric analysis for plasma von Willebrand factor degradation in diabetes mellitus using monoclonal antibodies recognizing protease-sensitive sites. Clin Biochem 1994; 27: 123-31.
13. Takeya H, Nishida S, Nishino N, Makinose Y, Omori-Satoh T, Nikai T, Sugihara H, Iwanaga S. Primary structures of platelet aggregation inhibitors (disintegrins) autoproteolytically released from snake venom hemorrhagic metalloproteinases and new fluorogenic peptide substrates for these enzymes. J Biochem (Tokyo) 1993; 113: 473-83.
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-85.
15. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987; 262: 10035-8.
16. 2-macroglobulin and von Willebrand factor possess covalently linked ABO(H) blood group antigens in subjects with corresponding ABO phenotype. Blood 1993; 82: 663-8.
17. Tomita Y, Harrison J, Abildgaard CF. von Willebrand factor multimer analysis using a sensitive peroxidase staining method. Thromb Haemost 1989; 62: 781-3.
18. Matsui T, Kunishima S, Hamako J, Katayama M, Kamiya T, Naoe T, Ozeki Y, Fujimura Y, Titani K. Interaction of von Willebrand factor with the extracellular matrix and glycocalicin under static conditions. J Biochem (Tokyo) 1997; 121: 376-81.
19. syk activation by an anti-glycoprotein Ib monoclonal antibody. Blood 1997; 89: 1590-8.
20. Miyake T, Nomura S, Kamiyama Y, Miyazaki Y, Kagawa H, Masuda M, Takahashi H, Fujimura Y, Ikeda Y, Fukuhara S. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. Thromb Haemost 1997; 78: 902-9.
21. Hamamoto, K, Nomura S, Suzuki M, Ohga S, Fukuhara S. Internalization of an anti-glycoprotein IIb/IIIa antibody by HEL cells. Thromb Haemost 1995; 73: 291-6.
22. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350-6.
23. Paine MJ, Desmond HP, Theakston RD, Crampton JM. Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom: insights into the disintegrin gene family. J Biol Chem 1992; 267: 22869-76.
24. Nishida S, Fujita T, Kohno N, Atoda H, Morita T, Takeya H, Jido I, Paine MJI, Kawabata S, Iwanaga S. cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from kenyan Echis carinatus venom. Biochemistry 1995; 34: 1771-8.
25. Takeya H, Arakawa M, Miyata T, Iwanaga S, Omori-Satoh T. Primary structure of H-2-proteinase, a non-hemorrhagic metalloproteinase, isolated from the venom of the habu snake, Trimeresurus flavoviridis. J Biochem (Tokyo) 1989; 106: 151-7.
26. Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin: a model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J Biol Chem 1991; 266: 18172-8.
27. Matsui T, Kihara C, Fujimura Y, Mizuochi T, Titani K. Carbohydrate analysis of human von Willebrand factor with horseradish peroxidase-conjugated lectins. Biochem Biophys Res Commun 1991; 178: 1253-9.
28. Feder J, Garrett LR, Wildi BS. Studies on the role of calcium in thermolysin. Biochemistry 1971; 10: 4552-6.
29. Iwanaga S, Takeya H. Structure and function of snake venom metalloproteinase family. In: Methods in Protein Sequence Analysis. Imahori K, Sakiyama F, eds. Plenum Press, New York 1993; 107-15.
30. Takeya H, Miyata T, Nishino N, Omori-Satoh T, Iwanaga S. Snake venom hemorrhagic and nonhemorrhagic metalloendopeptidases. Methods Enzymol 1993; 223: 365-78.
31. Usami Y, Fujimura Y, Miura S, Shima H, Yoshida E, Yoshioka A, Hirano K, Suzuki M, Tilani K. A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen-and ADP-induced platelet aggregation. Biochem Biophys Res Commun 1994; 201: 331-9.
32. Kamiguti AS, Hay CR, Threakston RD, Zuzel M. Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon 1996; 34: 627-42.
33. Kamiguti AS, Hay CR, Zuzel M. Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta I-integrin by the snake venom metalloproteinase jararhagin. Biochem J 1996; 320: 635-41.
34. Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Iba: identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry 1996; 35: 4929-38.
35. De Luca M, Dunlop LC, Andrews RK, Flannery JV Jr, Ettling R, Gumming DA, Veldman GM, Berndt MC. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1. and abolishes P-selectin binding. J Biol Chem 1995; 270: 26734-7.
36. Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE, Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochemistry 1986; 25: 3171-84.
37. Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor: mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 1992; 31: 11144-51.
38. Jentoft N. Why are proteins 0-glycosylated? Trends Biochem Sci 1990; 15: 291-4.
39. Casonato A, Pontara E, Bertomoro A, Zucchetto S, Zerbinati P, Girolami A. Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. J Lab Clin Med 1997; 129: 251-9.
40. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis, Blood 1996; 87: 4223-34.
41. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996; 87: 4235-44.
42. Tsai HM, Sussman II, Ginsburg D, Lankhof H, Sixma JJ, Nagel RL. Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-I. Blood 1997; 89: 1954-62.